The insulin called Afrezza is created and manufactured by MannKind Corporation, and is used to improve glycemic control in adults with diabetes mellitus.“Afrezza is a rapid-acting insulin ...
Cannulas can also bend, restricting the flow of insulin, and the pump can sometimes become disconnected from the tubing without the user noticing. The NHS only offers insulin pumps to those who ...
(Nasdaq: TNDM) and Dexcom, Inc. today announced that following the recent authorization of sale by Health Canada, in-warranty t:slim X2™ insulin pump users can now access full compatibility with ...
t:slim X2 pumps pre-loaded with the updated software will begin shipping to new customers in early January 2025. To check coverage and start the process of getting a Tandem insulin pump, please visit ...
A person wears the G7 (on the left arm) and t:slim X2 (on the waist). [Image courtesy of Tandem Diabetes Care] Tandem Diabetes Care (Nasdaq:TNDM) announced today that t:slim X2 insulin pump users in ...
Most people diagnosed with diabetes use either an insulin pen or an insulin pump to regulate their blood sugar. An insulin pen is a needle diabetics inject into their skin when insulin levels are too ...
Embecta will cut approximately 125 jobs in Andover, Massachusetts, after announcing last week that it will discontinue its insulin patch pump program, a company spokesperson told MedTech Dive in an ...
EOFlow Co. Ltd. must pay Insulet Corp. $452 million for stealing trade secrets related to its insulin pumps, a Massachusetts federal jury ruled. Insulet established the Korea-based company stole four ...
Insulin pump maker Insulet won $452 million in its trade secret case against Korean rival EOFlow, the company announced on Wednesday. The company filed a lawsuit against EOFlow in August 2023 ...
Insulet has dominated the U.S. market for insulin patch pumps: small, wearable devices intended to replace daily insulin injections. However, competitors Tandem Diabetes Care and Medtronic plan to ...